feed,title,long_url,short_url
Benzinga,"Hookipa Pharma's Cancer Immunotherapy Shows T-Cell Response, Interim Efficacy in Pretreated HPV16+ Cancer Settings",https://benzinga.com/general/biotech/21/06/21465426/hookipa-pharmas-cancer-immunotherapy-shows-t-cell-response-interim-efficacy-in-pretreated-hpv16-c,https://j.mp/3g1QF90
